.PurposeThis position is responsible to lead the assessment of Mexico earliest pipeline innovations to inform the future market access strategy, and to identify and enable opportunities for more innovative and accelerated approaches to access and reimbursement. Is also responsible for driving innovation across the GAV team and accountable for excellence in execution of access agreements with payers and other partners.Main ResponsibilitiesEarly Pipeline Access Strategy and Vision- Screening and evaluation of Pfizer pipeline products: gathering information on clinical developments/economic burden of disease in the Pfizer pipeline, ongoing evaluation and prioritization of pipeline products- Establishment and maintenance of a relevant network (national and international) with internal stakeholders and participation into Global initiatives to provide a Mexican public perspective.- Be responsible for the development and implementation of the access/pharmaeconomic model strategy for all specialties of the pipeline to support the global and local organization in the structuring choices of clinical/economic burden of disease studies development and thus optimize future launches in terms of value and speed to market.- Contribute to the achievement of Pfizer's strategic market access objectives for pipeline products, more specifically, the reduction of access times to the Mexican market and under the conditions of evaluation by the General Health Council.- Develop and implement plans and budget requirements for projects that support selected pipeline products reimbursement strategy.Innovative Access Agreements- Develop and implement project to elevate the internal and external capabilities in Innovative Agreements and Approach- Building and scaling innovative access agreements across the whole Pfizer portfolio and translating successful pilots/experiments into new business models.- Following up, rigorously tracking, and executing, evolving as needed, and where appropriate terminating, innovative agreement models, using the principles of disciplined experimentation.- Advancing the local adoption of new platforms to support the scaling of innovative agreements, e. g. blockchain capability.- Working directly with payers as needed to negotiate, design, and implement new business models/ways of working with Pfizer